Bradley Everly, MD
Family Medicine · Maumee, OHNPI 1053561993
Payments from drug & device makers
Across 473 payments — averaging $562.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- CSL Plasma Inc.$157K
- CSL Behring$107K
- AbbVie$388
- Novo Nordisk$264
- AstraZeneca$237
- Pfizer$219
- plus $1K from 25 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| CSL Plasma Inc. | 160 | $156,704 |
| CSL Behring | 129 | $106,955 |
| AbbVie(2 entities) | 29 | $388 |
| Novo Nordisk | 20 | $264 |
| AstraZeneca | 8 | $237 |
| Pfizer | 27 | $219 |
| GSK | 15 | $157 |
| Boehringer Ingelheim | 9 | $152 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $118 |
| Merck | 7 | $92 |
| Amgen | 6 | $88 |
| Amarin Pharma, Inc. | 6 | $85 |
| Lilly USA, LLC | 5 | $79 |
| Kowa Pharmaceuticals America, Inc. | 5 | $74 |
| Novartis | 5 | $73 |
| Johnson & Johnson | 5 | $70 |
| Eisai Inc. | 4 | $59 |
| Nestle Healthcare Nutrition Inc. | 3 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $47 |
| Jazz Pharmaceuticals Inc. | 3 | $44 |
| Teva Pharmaceuticals USA, Inc. | 2 | $29 |
| Almatica Pharma LLC | 2 | $28 |
| Biohaven Pharmaceuticals, Inc. | 2 | $27 |
| Mannkind Corporation | 2 | $24 |
| Hikma Pharmaceuticals USA | 1 | $16 |
| Ironwood Pharmaceuticals, Inc | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $15 |
| Harmony Biosciences LLC | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $13 |
| Ultragenyx Pharmaceutical Inc. | 1 | $11 |
How this compares
$266,158 in reported general payments places this provider in the 95th percentile of 3,983 family medicine providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other family medicine in Maumee
- Michael ButcherCincinnati$18.3M
- William RandallKettering$7.5M
- Paul NugentCincinnati$4.9M
- Steve ChoiDayton$4.8M
- Martin SchearDayton$2.2M
- Rajesh DavitCincinnati$2M
- Kwabena OtengSpringdale$2M
- Blaise GattoMoraine$1.8M
- Cathy GreiweColumbus$1.4M
- Brian BeesleyColumbus$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.